CLINICAL_TRIALS
trial_result
· 2018-05-04
Clinical Trial Update: To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs) [Phase 4]
Summary
Phase 4 clinical trial evaluating the long-term safety of HPN-100 for managing urea cycle disorders has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Urea Cycle Disorders | Phase 4 | Status: COMPLETED | Results posted: 2018-05-04